Search research articles
Contact Us
Filters
Showing results (141-150 of 425) with videos related to
Page
of 43
Sort By:
Vascular Health and Risk Management
|
November 21, 2012
Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
Elaine Chiquette, Peter P Toth, Gilbert Ramirez, et al.
Vascular Health and Risk Management
|
February 11, 2012
Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy
Peter P Toth, Kamlesh M Thakker, Ping Jiang, et al.
Vascular Health and Risk Management
|
June 9, 2016
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
Dirk J Blom, Ricardo Dent, Rita C Castro, et al.
Journal of Clinical Lipidology
|
August 19, 2017
Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps
Kevin C Maki, Orsolya M Palacios, Marjorie Bell, et al.
Expert Opinion on Pharmacotherapy
|
December 7, 2018
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children
Dragana Nikolic, Andreea Corina, Peter P Toth, et al.
Diabetes Care
|
October 3, 2019
Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014
Wenjun Fan, Sephy Philip, Craig Granowitz, et al.
The American Journal of Cardiology
|
September 16, 2020
REDUCE-IT Eligibility and Preventable Cardiovascular Events in the US Population (from the National Health and Nutrition Examination Survey [NHANES])
Nathan D Wong, Wenjun Fan, Sephy Philip, et al.
Journal of Clinical Lipidology
|
May 24, 2011
Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Paul N Hopkins, Peter P Toth, Christie M Ballantyne, et al.
Expert Review of Cardiovascular Therapy
|
March 13, 2010
Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker
Peter P Toth, Peter A McCullough, Michael S Wegner, et al.
Cardiology Journal
|
November 9, 2019
Prevalence of United States adults with triglycerides ≥ 135 mg/dL: NHANES 2007-2014
Wenjun Fan, Sephy Philip, Peter P Toth, et al.
Page
of 43
Search research articles
Search
Showing results (141-150 of 425) with videos related to
Sort By:
Page
of 43
Vascular Health and Risk Management
|
November 21, 2012
Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
Elaine Chiquette, Peter P Toth, Gilbert Ramirez, et al.
Vascular Health and Risk Management
|
February 11, 2012
Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy
Peter P Toth, Kamlesh M Thakker, Ping Jiang, et al.
Vascular Health and Risk Management
|
June 9, 2016
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
Dirk J Blom, Ricardo Dent, Rita C Castro, et al.
Journal of Clinical Lipidology
|
August 19, 2017
Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps
Kevin C Maki, Orsolya M Palacios, Marjorie Bell, et al.
Expert Opinion on Pharmacotherapy
|
December 7, 2018
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children
Dragana Nikolic, Andreea Corina, Peter P Toth, et al.
Diabetes Care
|
October 3, 2019
Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014
Wenjun Fan, Sephy Philip, Craig Granowitz, et al.
The American Journal of Cardiology
|
September 16, 2020
REDUCE-IT Eligibility and Preventable Cardiovascular Events in the US Population (from the National Health and Nutrition Examination Survey [NHANES])
Nathan D Wong, Wenjun Fan, Sephy Philip, et al.
Journal of Clinical Lipidology
|
May 24, 2011
Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Paul N Hopkins, Peter P Toth, Christie M Ballantyne, et al.
Expert Review of Cardiovascular Therapy
|
March 13, 2010
Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker
Peter P Toth, Peter A McCullough, Michael S Wegner, et al.
Cardiology Journal
|
November 9, 2019
Prevalence of United States adults with triglycerides ≥ 135 mg/dL: NHANES 2007-2014
Wenjun Fan, Sephy Philip, Peter P Toth, et al.
Page
of 43